This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Feb;59(2):165-7.

doi: 10.1053/j.ajkd.2011.12.001.

Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis

Paweena Susantitaphong, Bertrand L Jaber

PMID: 22243944
DOI: 10.1053/j.ajkd.2011.12.001

Editorial

Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis

Paweena Susantitaphong et al. Am J Kidney Dis. 2012 Feb.

. 2012 Feb;59(2):165-7.

doi: 10.1053/j.ajkd.2011.12.001.

Authors

Paweena Susantitaphong, Bertrand L Jaber

PMID: 22243944
DOI: 10.1053/j.ajkd.2011.12.001

No abstract available

PubMed Disclaimer

Comment on

Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Yilmaz MI, et al. Am J Kidney Dis. 2012 Feb;59(2):177-85. doi: 10.1053/j.ajkd.2011.11.007. Epub 2011 Dec 2. Am J Kidney Dis. 2012. PMID: 22137672 Clinical Trial.
Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C, Jahnen-Dechent W, Ketteler M, Floege J, Schurgers LJ. Westenfeld R, et al. Am J Kidney Dis. 2012 Feb;59(2):186-95. doi: 10.1053/j.ajkd.2011.10.041. Epub 2011 Dec 9. Am J Kidney Dis. 2012. PMID: 22169620 Clinical Trial.

Similar articles

Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Yilmaz MI, et al. Am J Kidney Dis. 2012 Feb;59(2):177-85. doi: 10.1053/j.ajkd.2011.11.007. Epub 2011 Dec 2. Am J Kidney Dis. 2012. PMID: 22137672 Clinical Trial.
How to manage functional vitamin K deficiency in CKD.
Busch M, Stein A, Stein G. Busch M, et al. Am J Kidney Dis. 2012 Jul;60(1):168. doi: 10.1053/j.ajkd.2012.02.341. Am J Kidney Dis. 2012. PMID: 22709597 No abstract available.
Consequences of vitamin K2 deficiency in hemodialysis patients.
Fusaro M, D'Angelo A, Gallieni M. Fusaro M, et al. Am J Kidney Dis. 2012 Jul;60(1):169. doi: 10.1053/j.ajkd.2012.03.021. Am J Kidney Dis. 2012. PMID: 22709599 No abstract available.
Ten-year experience with sevelamer and calcium salts as phosphate binders.
Raggi P, Vukicevic S, Moysés RM, Wesseling K, Spiegel DM. Raggi P, et al. Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S31-40. doi: 10.2215/CJN.05880809. Clin J Am Soc Nephrol. 2010. PMID: 20089501 Review.
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Savica V, Calò LA, Monardo P, Santoro D, Bellinghieri G. Savica V, et al. Nephrol Dial Transplant. 2006 Aug;21(8):2065-8. doi: 10.1093/ndt/gfl289. Epub 2006 Jun 9. Nephrol Dial Transplant. 2006. PMID: 16766546 Review. No abstract available.

See all similar articles

Cited by

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?
Dai L, Meijers BK, Bammens B, de Loor H, Schurgers LJ, Qureshi AR, Stenvinkel P, Evenepoel P. Dai L, et al. Toxins (Basel). 2020 May 27;12(6):351. doi: 10.3390/toxins12060351. Toxins (Basel). 2020. PMID: 32471179 Free PMC article.
The gut microbiome, kidney disease, and targeted interventions.
Ramezani A, Raj DS. Ramezani A, et al. J Am Soc Nephrol. 2014 Apr;25(4):657-70. doi: 10.1681/ASN.2013080905. Epub 2013 Nov 14. J Am Soc Nephrol. 2014. PMID: 24231662 Free PMC article. Review.
Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management.
Raju S, Saxena R. Raju S, et al. Nutrients. 2025 May 5;17(9):1587. doi: 10.3390/nu17091587. Nutrients. 2025. PMID: 40362897 Free PMC article. Review.
Strategies for Phosphate Control in Patients With CKD.
Barreto FC, Barreto DV, Massy ZA, Drüeke TB. Barreto FC, et al. Kidney Int Rep. 2019 Jun 20;4(8):1043-1056. doi: 10.1016/j.ekir.2019.06.002. eCollection 2019 Aug. Kidney Int Rep. 2019. PMID: 31440695 Free PMC article. Review.
The role of kidney transplantation and phosphate binder use in vitamin K status.
Jansz TT, Neradova A, van Ballegooijen AJ, Verhaar MC, Vervloet MG, Schurgers LJ, van Jaarsveld BC. Jansz TT, et al. PLoS One. 2018 Aug 30;13(8):e0203157. doi: 10.1371/journal.pone.0203157. eCollection 2018. PLoS One. 2018. PMID: 30161193 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information